These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090. Contreras-Ruiz L; Mir FA; Turpie B; Krauss AH; Masli S Exp Eye Res; 2016 Feb; 143():1-8. PubMed ID: 26463157 [TBL] [Abstract][Full Text] [Related]
3. Dysregulated Marginal Zone B Cell Compartment in a Mouse Model of Sjögren's Syndrome with Ocular Inflammation. Singh N; Chin I; Gabriel P; Blaum E; Masli S Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314337 [TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice. Turpie B; Yoshimura T; Gulati A; Rios JD; Dartt DA; Masli S Am J Pathol; 2009 Sep; 175(3):1136-47. PubMed ID: 19700744 [TBL] [Abstract][Full Text] [Related]
5. Topical Application of TGF-β-Activating Peptide, KRFK, Prevents Inflammatory Manifestations in the TSP-1-Deficient Mouse Model of Chronic Ocular Inflammation. Soriano-Romaní L; Contreras-Ruiz L; López-García A; Diebold Y; Masli S Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577496 [TBL] [Abstract][Full Text] [Related]
6. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse. Kim D; Kim JY; Jun HS Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731 [TBL] [Abstract][Full Text] [Related]
7. Immune modulation by rebamipide in a mouse model of Sjogren's syndrome via T and B cell regulation. Jin-Sil P; Sun-Hee H; SeungCheon Y; JeongWon C; Kyung-Ah J; Mi-La C; Sung-Hwan P Immunol Lett; 2019 Oct; 214():1-7. PubMed ID: 31421154 [TBL] [Abstract][Full Text] [Related]
9. Th17 cells play a critical role in the development of experimental Sjögren's syndrome. Lin X; Rui K; Deng J; Tian J; Wang X; Wang S; Ko KH; Jiao Z; Chan VS; Lau CS; Cao X; Lu L Ann Rheum Dis; 2015 Jun; 74(6):1302-10. PubMed ID: 24573745 [TBL] [Abstract][Full Text] [Related]
10. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome. Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293 [TBL] [Abstract][Full Text] [Related]
11. Mouse Models of Sjögren's Syndrome with Ocular Surface Disease. Masli S; Dartt DA Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266081 [TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells. Mir FA; Contreras-Ruiz L; Masli S Immunology; 2015 Dec; 146(4):547-56. PubMed ID: 26458493 [TBL] [Abstract][Full Text] [Related]
13. Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models. Zhou J; Felix FA; Jiang Y; Li D; Kim MC; Jang D; Cha S; Yu Q Mol Immunol; 2024 Oct; 174():47-56. PubMed ID: 39197397 [TBL] [Abstract][Full Text] [Related]
14. Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. Contreras-Ruiz L; Regenfuss B; Mir FA; Kearns J; Masli S PLoS One; 2013; 8(9):e75937. PubMed ID: 24086667 [TBL] [Abstract][Full Text] [Related]
15. IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome. Alunno A; Bistoni O; Bartoloni E; Caterbi S; Bigerna B; Tabarrini A; Mannucci R; Falini B; Gerli R Ann Rheum Dis; 2013 Feb; 72(2):286-92. PubMed ID: 22904262 [TBL] [Abstract][Full Text] [Related]
16. Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases. Nanke Y; Kobashigawa T; Yago T; Kawamoto M; Yamanaka H; Kotake S Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(5):473-477. PubMed ID: 27795505 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome. Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818 [TBL] [Abstract][Full Text] [Related]
18. Critical involvement of macrophage infiltration in the development of Sjögren's syndrome-associated dry eye. Zhou D; Chen YT; Chen F; Gallup M; Vijmasi T; Bahrami AF; Noble LB; van Rooijen N; McNamara NA Am J Pathol; 2012 Sep; 181(3):753-60. PubMed ID: 22770665 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor mediates the interplay between CD4+ T cells and ocular resident cells to promote keratinizing squamous metaplasia in Sjögren's syndrome. Chen YT; Lazarev S; Bahrami AF; Noble LB; Chen FY; Zhou D; Gallup M; Yadav M; McNamara NA Lab Invest; 2012 Apr; 92(4):556-70. PubMed ID: 22231738 [TBL] [Abstract][Full Text] [Related]
20. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review. Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]